0001882782-22-000002.txt : 20221027 0001882782-22-000002.hdr.sgml : 20221027 20221027093039 ACCESSION NUMBER: 0001882782-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221027 DATE AS OF CHANGE: 20221027 EFFECTIVENESS DATE: 20221027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Odyssey Therapeutics, Inc. CENTRAL INDEX KEY: 0001882782 IRS NUMBER: 863384382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-462964 FILM NUMBER: 221335197 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (212) 841-1000 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001882782 Odyssey Therapeutics, Inc. 301 BINNEY STREET CAMBRIDGE MA MASSACHUSETTS 02142 (212) 841-1000 DELAWARE None None Corporation true 2021 Gary D Glick 301 Binney Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Carl Gordon 301 Binney Street Cambridge MA MASSACHUSETTS 02142 Director Jill Carroll 301 Binney Street Cambridge MA MASSACHUSETTS 02142 Director Valerie Odegard 301 Binney Street Cambridge MA MASSACHUSETTS 02142 Director Charles Baum 301 Binney Street Cambridge MA MASSACHUSETTS 02142 Director Jeffrey Leiden 301 Binney Street Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2022-05-13 false true false 0 174909939 168009933 6900006 false 34 0 0 0 false Odyssey Therapeutics, Inc. /s/ Gary D. Glick Gary D. Glick President & CEO 2022-10-27